Previsioni di mercato della bioproduzione in Sud e Centro America fino al 2030 - Analisi regionale - per prodotto (prodotti biologici e biosimilari, vaccini, terapie cellulari e geniche, terapie con acidi nucleici e altri), applicazione (artrite reumatoide, disturbi ematologici, cancro, diabete, malattie cardiovascolari, e altri), apparecchiature (apparecchiature a monte, apparecchiature a valle, bioreattori, materiali di consumo e accessori) e utente finale (aziende biofarmaceutiche, organizzazioni di produzione a contratto e altri)
La scadenza del brevetto dei prodotti biologici di successo alimenta il mercato della bioproduzione in Sud e Centro America
I prodotti biologici rappresentano nuove terapie promettenti per malattie precedentemente incurabili e stanno diventando molto importanti nel mercato farmaceutico. Si prevede che i brevetti sui prodotti biologici originali scadranno nei prossimi anni.
Le date di scadenza stimate dei brevetti e dell\'esclusività per i prodotti biologici più venduti sono riportate nella tabella seguente.
Prodotti biologici
Date di scadenza
Avastin
Gennaio 2022
Cyramza
Maggio 2023
Adcetris
Agosto 2023
Abthrax
Ottobre 2024
Gazyva/ Gazyvaro
Novembre 2024
Darzalex
Maggio 2026
Ocrevus
Aprile 2027
Emgality
Settembre 2028
Hemlibra
Febbraio 2028
Llumetri
Marzo 2028
Imfinzi
Settembre 2028
Mylotarg
Aprile 2028
Imfinzi
Settembre 2028
Mylotarg
Aprile 2028
Sylvant
Luglio 2034
The la scadenza dei brevetti e altri diritti di proprietà intellettuale per i prodotti biologici originali creeranno la necessità di introdurre nuovi biosimilari in futuro. Di conseguenza, nei prossimi anni la concorrenza tra gli operatori del mercato aumenterà nel settore. Pertanto, si prevede che la scadenza dei brevetti dei prodotti biologici di successo creerà opportunità redditizie per il mercato della bioproduzione durante il periodo di previsione.
Panoramica del mercato della bioproduzione nell\'America meridionale e centrale
Il mercato della bioproduzione nell\'America meridionale e centrale è suddiviso in Brasile, Argentina e nel resto dell\'America meridionale e centrale. I crescenti sviluppi nel settore medico e la crescente consapevolezza riguardo alla terapia cellulare in Brasile creeranno probabilmente significative opportunità di crescita per la crescita del mercato. Allo stesso modo, si prevede che il crescente settore sanitario in Argentina offra opportunità di crescita per il mercato della bioproduzione.
Secondo un articolo pubblicato su Biomaterials Research, nel 2020, il Brasile era tra i primi dieci paesi al mondo in termini di maggior numero di persone affette da diabete e attualmente è al quinto posto. Attualmente, il Brasile è il quinto paese al mondo con la più alta prevalenza di diabete mellito (DM) negli adulti. Secondo la International Diabetes Federation (IDF), si stima un aumento del 54,7% dei nuovi casi di diabete entro il 2045.
Secondo GaBI, nel 2022, l\'Agenzia brasiliana di regolamentazione sanitaria (Agência Nacional de Vigilância Sanitária, ANVISA ) ha approvato 30 biosimilari appartenenti alle classi di prodotti insulina, anticorpi monoclonali, inibitori del fattore di necrosi tumorale (TNF), ormone umano della crescita, anticoagulanti ed eparine e fattore stimolante le colonie di granulociti per l\'uso in Brasile. L\'ANVISA ha approvato il biosimilare Admelog di Sanofi in Brasile per il trattamento del diabete. Pertanto, l’aumento dei casi di diabete e l’aumento delle approvazioni dei prodotti in Brasile stanno guidando il mercato della bioproduzione.
Entrate e previsioni del mercato della bioproduzione dell\'America meridionale e centrale fino al 2030 (milioni di dollari)
Segmentazione del mercato della bioproduzione dell\'America meridionale e centrale
Il mercato della bioproduzione dell\'America meridionale e centrale è classificato in prodotto, applicazione, attrezzatura, utente finale e paese.
In base al prodotto, il mercato della bioproduzione del Sud e Centro America è segmentato in prodotti biologici e biosimilari, vaccini, terapie cellulari e geniche, terapie con acidi nucleici e altri. Il segmento dei prodotti biologici e biosimilari ha detenuto la maggiore quota di mercato della bioproduzione in Sud e Centro America nel 2022.
In termini di applicazione, il mercato della bioproduzione in Sud e Centro America è segmentato in artrite reumatoide, disturbi ematologici, cancro, diabete, malattie cardiovascolari e altri. Nel 2022, il segmento del cancro deteneva la maggiore quota di mercato della bioproduzione in Sud e Centro America.
In base alle apparecchiature, il mercato della bioproduzione del Sud e Centro America è suddiviso in apparecchiature a monte, apparecchiature a valle, bioreattori e materiali di consumo e accessori. Il segmento dei materiali di consumo e degli accessori ha detenuto la maggiore quota di mercato della bioproduzione in Sud e Centro America nel 2022.
In termini di utente finale, il mercato della bioproduzione in Sud e Centro America è classificato in aziende biofarmaceutiche, organizzazioni di produzione a contratto e altri. Nel 2022, il segmento delle aziende biofarmaceutiche deteneva la maggiore quota di mercato della bioproduzione dell\'America meridionale e centrale.
Per paese, il mercato della bioproduzione dell\'America meridionale e centrale è segmentato in Brasile, Argentina e il resto dell\'America meridionale e centrale. Il Brasile ha dominato la quota di mercato della bioproduzione dell\'America centrale e meridionale nel 2022.
Lonza Group AG, Danaher Corp, Sartorius AG, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd e Bio-Rad Laboratories Inc. sono alcune delle aziende leader che operano nel mercato della bioproduzione del Sud e Centro America.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - South & Central America Market Analysis
5.1 South & Central America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 South & Central America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 South & Central America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 South & Central America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 South & Central America: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 South & Central America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 South & Central America: Bioproduction Market
10.1.1 South & Central America: Bioproduction Market Share by Country - 2022 & 2030, (%)
10.1.1.1 Brazil: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2 Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
10.1.1.2.1 Brazil: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.2 Brazil: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.2.3 Brazil: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.2.3.1 Brazil: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.4 Brazil: Bioproduction Market, By End User, 2020-2030 (US$ Million)
10.1.1.3 Argentina: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.4 Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
10.1.1.4.1 Argentina: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.2 Argentina: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.4.3 Argentina: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.4.3.1 Argentina: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.4 Argentina: Bioproduction Market, By End User, 2020-2030 (US$ Million)
10.1.1.5 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.6 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Rest of South & Central America: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.2 Rest of South & Central America: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.6.3 Rest of South & Central America: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.6.3.1 Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of South & Central America: Bioproduction Market, By End User, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. South & Central America Bioproduction Market Segmentation
Table 2. South & Central America Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. Brazil: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of South & Central America: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 19. Recent Organic Growth Strategies in the Bioproduction Market
Table 20. Glossary of Terms, Bioproduction Market
List of Figures
Figure 1. South & Central America Bioproduction Market Segmentation, By Country
Figure 2. South & Central America Bioproduction Market: Key Industry Dynamics
Figure 3. South & Central America Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. South & Central America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. South & Central America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. South & Central America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. South & Central America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. South & Central America: Bioproduction Market, By Key Country - Revenue (2022) (US$ Million)
Figure 28. South & Central America: Bioproduction Market Share by Country - 2022 & 2030, (%)
Figure 29. Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 30. Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 31. Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in the Bioproduction Market
1. Lonza Group AG
2. Danaher Corp
3. Sartorius AG
4. Thermo Fisher Scientific Inc
5. Merck KGaA
6. F. Hoffmann-La Roche Ltd
7. Bio-Rad Laboratories Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.